The Daily Have We Been Thinking About A.D.H.D. All Wrong?
899 snips
Jun 17, 2025 
In this discussion, Paul Tough, a seasoned writer for The New York Times Magazine, delves into the rising prevalence of ADHD diagnoses and treatment. He questions traditional methods of identification and treatment, urging a shift in understanding the disorder. Tough shares personal narratives highlighting the emotional struggles of those with ADHD. He advocates for supportive environments over solely relying on medication, emphasizing the importance of holistic approaches to help children thrive.
AI Snips
Chapters
Transcript
Episode notes
Edmund Sanuga-Bark's ADHD Journey
- Edmund Sanuga-Bark was diagnosed with ADHD in childhood when it was called hyperkinesis in the UK.
- He struggled in school but eventually thrived in university, dedicating his life to studying ADHD.
Rethinking ADHD Definition and Biomarkers
- Researchers question if ADHD is a clear-cut biological condition or a spectrum with blurred boundaries.
- The search for a simple biomarker to definitively diagnose ADHD has been largely unsuccessful.
ADHD Medication’s Long-Term Effectiveness
- Stimulant medications improve ADHD symptoms short-term, but benefits fade after about three years.
- Long-term, those on medication perform similarly to peers receiving behavioral treatments or no treatment.